Skip to main content
. 2021 Feb 8;22:52. doi: 10.1186/s12859-021-03988-x

Fig. 6.

Fig. 6

The guilt-by-association principle behind our in silico drug repositioning. If a drug with unknown indication profile shares a similar property with another drug whose indication profile is known, the former may share the same indication profile with the latter